Understanding post-operative outcomes in Crohn's disease after ileocecal resection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients with Crohn's disease who are scheduled for ileocecal resection. It aims to collect extensive clinical and biological data to better understand factors influencing post-operative recurrence of the disease. Patients will undergo surgery, and various samples will be collected for analysis, including blood and biopsies. The study will also track clinical outcomes through endoscopic examinations scheduled after surgery to assess recurrence risk.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Informed consent obtained before any study-related activities
* A diagnosis of CD, based on clinical, radiologic, endoscopic, or histological evidence.
* Men and women ≥18 years of age
* Required surgical intervention consisting in an ileocecal resection

Exclusion Criteria:

* Previous history of dysplasia or cancer in the ileum or colon
* Unwillingness or inability to follow the procedures outlined in the protocol
* Pregnant women

Where it's running

• SART Tilman Hospital
  Liège, Belgium Recruiting
• Amiens Hospital
  Amiens, France Recruiting
• Clermont-Ferrand Hospital
  Clermont-Ferrand, France Recruiting
• Beaujon Hospital
  Clichy, France Recruiting
• Henri Mondor Hospital
  Créteil, France Recruiting
• Kremlin-Bicêtre Hospital
  Le Kremlin-Bicêtre, France Recruiting

Study contacts

• Principal investigator: Matthieu ALLEZ, Pr — Remind
• Study coordinator: Matthieu ALLEZ, Pr
• Email: Matthieu.allez@aphp.fr
• Phone: +33(1) 42 49 95 75

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Microencapsulated Propionate vs Butyrate for Crohn's Disease in Remission

  This study tests whether microencapsulated sodium propionate can favorably alter the gut microbiota and inflammation in adults with Crohn’s disease, compared with sodium butyrate.

  Recruiting University of Padova · Padova · NCT07883044

• Risankizumab for Refractory Perianal Fistulizing Crohn's Disease

  This study tests whether risankizumab can help people with Crohn’s disease who have draining perianal fistulas not responding to other treatments.

  Recruiting Phase 4 Hyogo Medical University · Nishinomiya and 3 other locations · NCT07872449

• Intestinal ultrasound-guided management for inflammatory bowel disease

  This study tests if adding point-of-care intestinal ultrasound at every visit changes treatment decisions for adults with Crohn’s disease or ulcerative colitis undergoing disease assessment.

  Recruiting Mahidol University · Bangkok · NCT07775352

• Laser-based sizing of GI lesions during endoscopies

  This study tests whether the AccuMeasure laser tool gives more accurate and reliable lesion size measurements during colonoscopies for adults with colon polyps or Crohn’s disease than traditional endoscopic estimates.

  Recruiting Centre hospitalier de l'Université de Montréal (CHUM) · Montreal, Quebec · NCT07770425

• A Probiotic Approach to Modulating Gut Microbiota in Mild-to-Moderate Ulcerative Colitis

  A specific probiotic given rectally will be tested in adults with mild-to-moderate ulcerative colitis to see if it can help manage symptoms.

  Recruiting Catholic University of the Sacred Heart · Roma, RM · NCT07724990

• Claudin-2 Immunostaining to Detect Active or Inactive Inflammation in IBD Biopsies

  This study tests whether staining for Claudin-2 in intestinal biopsy samples can help identify active vs. inactive inflammation in people with ulcerative colitis or Crohn's disease.

  Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Mi · NCT07710287

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.